Janux Therapeutics Other Long Term Liabilities (Quarterly) Analysis

Janux Therapeutics, Inc. (JANX)

14.08 +0.29 (+2.10%) USD | NASDAQ | Jan 14, 14:23

View Other Long Term Liabilities (Quarterly) for JANX.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Other Long Term Liabilities (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Other Long Term Liabilities (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Other Long Term Liabilities (Quarterly) Benchmarks

Start Trial

Eli Lilly & Co.	Upgrade
Ionis Pharmaceuticals, Inc.	Upgrade
MannKind Corp.	Upgrade
Madrigal Pharmaceuticals, Inc.	--
Editas Medicine, Inc.	Upgrade